BECAUSE the technique of percutaneous transluminal angioplasty (PTA) has therapeutic potential and is of increasing interest to physicians,1-3 the American Medical Association's Council on Scientific Affairs, in December 1981, established a panel to review medical knowledge about this new technique and to assess experience with it to date. The Council requested that the panel report on the therapeutic use of PTA in the iliofemoral, coronary, and renal artery beds. The panel's report follows.
The main principle of PTA is the same, whether the procedure is used in the iliofemoral, renal, or coronary artery bed.2 A double-lumen dilation catheter, with a strong, nonelastic balloon made of polyvinyl chloride or polyethylene annealed to the tip, is introduced into a mainstream vessel, either directly through the skin or by cutdown. Then the catheter is guided to the site of the lesion and positioned so that the balloon segment lies
Percutaneous Transluminal Angioplasty. JAMA. 1984;251(6):764–768. doi:10.1001/jama.1984.03340300056031
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: